These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24307265)

  • 1. c-Met inhibition in a HOXA9/Meis1 model of CN-AML.
    Mulgrew NM; Kettyle LM; Ramsey JM; Cull S; Smyth LJ; Mervyn DM; Bijl JJ; Thompson A
    Dev Dyn; 2014 Jan; 243(1):172-81. PubMed ID: 24307265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
    Calvo KR; Sykes DB; Pasillas MP; Kamps MP
    Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.
    Li Z; Chen P; Su R; Hu C; Li Y; Elkahloun AG; Zuo Z; Gurbuxani S; Arnovitz S; Weng H; Wang Y; Li S; Huang H; Neilly MB; Wang GG; Jiang X; Liu PP; Jin J; Chen J
    Cancer Res; 2016 Feb; 76(3):619-29. PubMed ID: 26747896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice.
    Staffas A; Arabanian LS; Wei SY; Jansson A; Ståhlman S; Johansson P; Fogelstrand L; Cammenga J; Kuchenbauer F; Palmqvist L
    Oncogene; 2017 Mar; 36(11):1516-1524. PubMed ID: 27617578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia.
    Thorsteinsdottir U; Kroon E; Jerome L; Blasi F; Sauvageau G
    Mol Cell Biol; 2001 Jan; 21(1):224-34. PubMed ID: 11113197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes.
    Wang GG; Pasillas MP; Kamps MP
    Mol Cell Biol; 2006 May; 26(10):3902-16. PubMed ID: 16648484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factor AP-2α regulates acute myeloid leukemia cell proliferation by influencing Hoxa gene expression.
    Ding X; Yang Z; Zhou F; Wang F; Li X; Chen C; Li X; Hu X; Xiang S; Zhang J
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1647-56. PubMed ID: 23660297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia.
    Musialik E; Bujko M; Kober P; Grygorowicz MA; Libura M; Przestrzelska M; Juszczyński P; Borg K; Florek I; Jakóbczyk M; Siedlecki JA
    Mol Med Rep; 2015 May; 11(5):3948-54. PubMed ID: 25585874
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Wang W; Li H; Huang M; Wang X; Li W; Qian X; Jing L
    Open Biol; 2022 Oct; 12(10):220172. PubMed ID: 36285442
    [No Abstract]   [Full Text] [Related]  

  • 10. MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells.
    Schneider E; Pochert N; Ruess C; MacPhee L; Escano L; Miller C; Krowiorz K; Delsing Malmberg E; Heravi-Moussavi A; Lorzadeh A; Ashouri A; Grasedieck S; Sperb N; Kumar Kopparapu P; Iben S; Staffas A; Xiang P; Rösler R; Kanduri M; Larsson E; Fogelstrand L; Döhner H; Döhner K; Wiese S; Hirst M; Keith Humphries R; Palmqvist L; Kuchenbauer F; Rouhi A
    Leukemia; 2020 May; 34(5):1253-1265. PubMed ID: 31768018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Entinostat prevents leukemia maintenance in a collaborating oncogene-dependent model of cytogenetically normal acute myeloid leukemia.
    Ramsey JM; Kettyle LM; Sharpe DJ; Mulgrew NM; Dickson GJ; Bijl JJ; Austin P; Mayotte N; Cellot S; Lappin TR; Zhang SD; Mills KI; Krosl J; Sauvageau G; Thompson A
    Stem Cells; 2013 Jul; 31(7):1434-45. PubMed ID: 23592435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Hox expression in murine embryonic stem cell models of normal and malignant hematopoiesis.
    Wheadon H; Ramsey JM; Dobbin E; Dickson GJ; Corrigan PM; Freeburn RW; Thompson A
    Stem Cells Dev; 2011 Aug; 20(8):1465-76. PubMed ID: 21083428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus.
    Wang GG; Pasillas MP; Kamps MP
    Blood; 2005 Jul; 106(1):254-64. PubMed ID: 15755900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOXA9 modulates its oncogenic partner Meis1 to influence normal hematopoiesis.
    Hu YL; Fong S; Ferrell C; Largman C; Shen WF
    Mol Cell Biol; 2009 Sep; 29(18):5181-92. PubMed ID: 19620287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid Leukemia.
    Mohr S; Doebele C; Comoglio F; Berg T; Beck J; Bohnenberger H; Alexe G; Corso J; Ströbel P; Wachter A; Beissbarth T; Schnütgen F; Cremer A; Haetscher N; Göllner S; Rouhi A; Palmqvist L; Rieger MA; Schroeder T; Bönig H; Müller-Tidow C; Kuchenbauer F; Schütz E; Green AR; Urlaub H; Stegmaier K; Humphries RK; Serve H; Oellerich T
    Cancer Cell; 2017 Apr; 31(4):549-562.e11. PubMed ID: 28399410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-155 is upregulated in MLL-rearranged AML but its absence does not affect leukemia development.
    Schneider E; Staffas A; Röhner L; Krowiorz K; Heuser M; Döhner K; Bullinger L; Döhner H; Fogelstrand L; Rouhi A; Kuchenbauer F; Palmqvist L
    Exp Hematol; 2016 Dec; 44(12):1166-1171. PubMed ID: 27619068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IDH2 and NPM1 Mutations Cooperate to Activate Hoxa9/Meis1 and Hypoxia Pathways in Acute Myeloid Leukemia.
    Ogawara Y; Katsumoto T; Aikawa Y; Shima Y; Kagiyama Y; Soga T; Matsunaga H; Seki T; Araki K; Kitabayashi I
    Cancer Res; 2015 May; 75(10):2005-16. PubMed ID: 25795706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linkage of Meis1 leukemogenic activity to multiple downstream effectors including Trib2 and Ccl3.
    Argiropoulos B; Palmqvist L; Yung E; Kuchenbauer F; Heuser M; Sly LM; Wan A; Krystal G; Humphries RK
    Exp Hematol; 2008 Jul; 36(7):845-59. PubMed ID: 18375036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b.
    Kroon E; Krosl J; Thorsteinsdottir U; Baban S; Buchberg AM; Sauvageau G
    EMBO J; 1998 Jul; 17(13):3714-25. PubMed ID: 9649441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flt3 is dispensable to the Hoxa9/Meis1 leukemogenic cooperation.
    Morgado E; Albouhair S; Lavau C
    Blood; 2007 May; 109(9):4020-2. PubMed ID: 17202314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.